Target Price | $11.00 |
Price | $7.46 |
Potential |
47.45%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target Maravai LifeSciences 2025 .
The average Maravai LifeSciences target price is $11.00.
This is
47.45%
register free of charge
$17.00
127.88%
register free of charge
$7.00
6.17%
register free of charge
|
|
A rating was issued by 15 analysts: 11 Analysts recommend Maravai LifeSciences to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Maravai LifeSciences stock has an average upside potential 2025 of
47.45%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 288.95 | 275.58 |
67.28% | 4.63% | |
EBITDA Margin | 15.43% | 20.66% |
78.16% | 33.91% | |
Net Margin | -44.07% | -12.94% |
264.69% | 70.64% |
13 Analysts have issued a sales forecast Maravai LifeSciences 2024 . The average Maravai LifeSciences sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Maravai LifeSciences EBITDA forecast 2024. The average Maravai LifeSciences EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Maravai LifeSciences Analysts have issued a net profit forecast 2024. The average Maravai LifeSciences net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.90 | -0.25 |
153.89% | 72.22% | |
P/E | negative | |
EV/Sales | 5.02 |
5 Analysts have issued a Maravai LifeSciences forecast for earnings per share. The average Maravai LifeSciences <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Maravai LifeSciences stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Maravai LifeSciences...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.